Price Chart

Executive Summary

T3 Defense unwound its acquisition of a 60% stake in Project 35 Ltd., returning the 168,479 shares it issued and canceling a $1.25M note. Separately, the company disclosed that a massive 1.34M share issuance from S-8, Series B conversions, and warrant exercises ballooned its share count to 3,008,775 from 1,663,806 in just two weeks — an 81% dilution that dramatically reduces per-share value for existing holders.

Key Facts

• Cancelled the acquisition of 60% of Project 35 Ltd. — returned 168,479 DFNS shares and cancelled a $1.25M 12% note due July 2027.
• Share count surged from 1,663,806 (Aug 14, 2026) to 3,008,775 (post-Aug 28) due to issuance of 1,344,969 new shares.
• Massive dilution of 80.9% in ~2 weeks from S-8, Series B convertible conversions, and warrant exercises.
• Parties released all claims; the acquisition is fully unwound. Discussions for a joint venture or product purchases continue - no binding terms.

Financial Impact

Share count increase of 80.9% represents massive dilution to existing common shareholders. The $1.25M note cancellation removes a liability but is dwarfed by the dilution impact.

Risk Factors

• Massive 81% dilution in two weeks signals potential desperate capital raising — further dilution from remaining warrants/convertibles likely.
• Return of the 60% Project 35 stake removes the sole disclosed operating asset, leaving T3 as a shell-like entity dependent on future unidentified deals.
• At a $20M market cap, the 1.34M new shares represent over $16M in potential selling pressure from the recipients of those shares.
• Going-concern risk heightened — no revenue or business operations disclosed; the cancelled acquisition and return of consideration leave the company without a clear operating path.

Market Snapshot

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

US Market Status